Document Detail


Prenatal diagnosis of beta-thalassaemia in Pakistan: experience in a Muslim country.
MedLine Citation:
PMID:  10820404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A service for prenatal diagnosis of beta-thalassaemia was introduced in Pakistan in May 1994. Two renowned Islamic scholars, consulted before the service was introduced, ruled that a pregnancy can be terminated if the fetus is affected by a serious genetic disorder, and if termination is before 120 days (17 weeks) of gestation. During the first 3(1/2) years of the service 300 couples requested the test. Almost all the couples had been informed by their treating doctors. Most diagnoses were made between 10 and 16 weeks of gestation, and only 15 (5%) were reached after the 16th week. DNA analysis was by the amplification refractory mutation system (ARMS). A multiplex ARMS was developed in which three primer combinations identified the mutations in 91.5% of the couples. In 13 couples (4. 3%) linkage analysis was required for the fetal diagnosis. In 47/53 (88.7%) women carrying an affected fetus the pregnancy was terminated. In six cases it was declined principally on religious grounds. Postnatal confirmation of the prenatal diagnosis was possible in 117 unaffected children. One year after the start of the service, interviews with 141 couples with an affected child showed that 72% knew of the availability of prenatal diagnosis. Thirty-two of the informed couples had had a pregnancy, but only 18 (56%) used prenatal diagnosis. The main reasons for non-utilization of prenatal diagnosis were the cost of the test and fear of undergoing the test, though some gave no clear explanation. This study demonstrates that prenatal diagnosis is feasible and acceptable in a Muslim country such as Pakistan.
Authors:
S Ahmed; M Saleem; N Sultana; Y Raashid; A Waqar; M Anwar; B Modell; K A Karamat; M Petrou
Related Documents :
2178414 - Incidence and timing of pregnancy losses: relevance to evaluating safety of early prena...
17108194 - Fetal dna in maternal plasma: progress through epigenetics.
3528044 - Prenatal diagnosis of genetic diseases.
16757914 - Prenatal two- and three-dimensional ultrasound diagnosis of limb reduction defects asso...
15037414 - Cell-free fetal dna levels in maternal plasma after elective first-trimester terminatio...
8933924 - Fetal abdominal protuberance ratio throughout pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  20     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2000 May 
Date Detail:
Created Date:  2000-06-30     Completed Date:  2000-06-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  378-83     Citation Subset:  IM    
Copyright Information:
Copyright 2000 John Wiley & Sons, Ltd.
Affiliation:
Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Attitude
Chorionic Villi Sampling
DNA / analysis
DNA Mutational Analysis
Female
Gestational Age
Humans
Islam*
Pakistan
Patient Education as Topic
Polymerase Chain Reaction
Pregnancy
Prenatal Diagnosis* / psychology
beta-Thalassemia / diagnosis*,  genetics*
Chemical
Reg. No./Substance:
9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA based prenatal testing for the skin blistering disorder epidermolysis bullosa simplex.
Next Document:  Prenatal diagnosis of inherited satellited non-acrocentric chromosomes.